Santa Ana Bio
Santa Ana Bio is a precision immunology company developing targeted therapies to stop autoimmune and inflammatory disease at the source. The company pairs a multi-omics discovery platform (integrating genomic, transcriptomic, and proteomic data) with a pipeline of bispecific and multi-specific antibody and antibody-drug-conjugate programs (SAB01, SAB05, SAB06) advancing toward IND submissions across 2026-2027. Backed by a16z and GV, it was added to the API Evangelist network as a portfolio company. It publishes a corporate and careers website but no public developer, API, or documentation surface.
Santa Ana Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Immunology, Autoimmune Disease, and Drug Discovery.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API